US FDA exempts more than 100 devices from 510(k) requirements
This article was originally published in SRA
The US Food and Drug Administration has exempted over 100 Class I and II medical devices from pre-market notification, or 510(k), requirements as it believes these products are sufficiently well understood and do not present risks that require pre-market notification review to assure their safety and effectiveness1,2.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.